| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2002 | CA2134783C Use of remacemide for the treatment of parkinson's disease |
| 08/13/2002 | CA2127987C Pharmaceutical bacteriocin compositions |
| 08/13/2002 | CA2122604C Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/13/2002 | CA2111447C Hypoglycemic thiazolidinediones and intermediates |
| 08/13/2002 | CA2095526C Compound and compositions useful as antifungal agents |
| 08/13/2002 | CA2088994C Therapeutically active mixture of glutathion and anthocyan compounds |
| 08/13/2002 | CA2063938C Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
| 08/13/2002 | CA2060573C N-(aryloxyalkyl)heteroaryl-8-azabicyclo¬3.2.1|octanes, intermediates and a process for the preparation thereof and their use as medicaments |
| 08/13/2002 | CA2039120C Complexes of tiaprofenic acid, or of its insoluble or partly insoluble esters, with cyclodextrines or their derivatives |
| 08/12/2002 | CA2370236A1 Method for inhibiting retinoid skin damage |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061128A2 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061090A2 Prokaryotically produced antibodies and uses thereof |
| 08/08/2002 | WO2002060972A2 Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060916A1 Methods for producing sterol ester-rich compositions |
| 08/08/2002 | WO2002060911A2 C-glucosyl ether lipids |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060902A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060892A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060880A1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060877A1 Imidazole derivatives |
| 08/08/2002 | WO2002060876A1 Triaryl compounds and utilization thereof |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060873A1 3-(3-amidinophenyl)-5-[({[1-(1-(-iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | WO2002060871A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | WO2002060870A2 Delta agonist analgesics |
| 08/08/2002 | WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 08/08/2002 | WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060857A1 Form a of fluoxetine hydrochloride |
| 08/08/2002 | WO2002060535A1 Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2? |
| 08/08/2002 | WO2002060534A2 Selective alpha 1 antagonists a + d |
| 08/08/2002 | WO2002060533A2 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects |
| 08/08/2002 | WO2002060532A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | WO2002060495A1 Procedure and composition of treatment and/or care of the eye |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 08/08/2002 | WO2002060486A2 Controlled release microsphere system for administration of drug to the eye |
| 08/08/2002 | WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | WO2002060483A2 Perylenequinones for use as photosensitizers and sonosensitizers |
| 08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
| 08/08/2002 | WO2002060471A2 Ligands for receptor-like protein tyrosine phosphatases |
| 08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | WO2002060463A1 Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same |
| 08/08/2002 | WO2002060462A2 Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it |
| 08/08/2002 | WO2002060460A1 Remedies for cancer |
| 08/08/2002 | WO2002060457A1 Anti-stress agents |
| 08/08/2002 | WO2002060456A1 Treatment of angiogenesis-dependent conditions with dextrin sulphates |
| 08/08/2002 | WO2002060455A1 Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferation |
| 08/08/2002 | WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | WO2002060453A1 Remedies for lung cancer |
| 08/08/2002 | WO2002060452A2 Use of carbohydrates for eliminating intestinal infections in animals |
| 08/08/2002 | WO2002060451A1 Method of treating certain eye diseases |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002060448A1 Medicinal composition |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060446A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060444A1 Muscarinic receptor agonists |
| 08/08/2002 | WO2002060443A1 Thiazolidinediones |
| 08/08/2002 | WO2002060442A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide |
| 08/08/2002 | WO2002060441A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide |
| 08/08/2002 | WO2002060439A1 Analgesic and antiinflammatory drugs |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060437A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | WO2002060436A2 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060433A1 Watery solution of copper and zinc chelates for the treatment of animals |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2002060431A1 Remedies/preventives for inflammatory diseases |
| 08/08/2002 | WO2002060430A1 Use of retinoids plus histone deacetylase inhibitors to inhibit the growth of solid tumors |
| 08/08/2002 | WO2002060429A1 Preservation of body protein |
| 08/08/2002 | WO2002060428A2 Methods of using and compositions comprising (-)sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060427A2 Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060426A2 Compounds regulating cell proliferation and differentiation |
| 08/08/2002 | WO2002060424A2 Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 08/08/2002 | WO2002060422A2 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | WO2002060421A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | WO2002060419A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 08/08/2002 | WO2002060418A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 08/08/2002 | WO2002060415A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |